These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35767740)

  • 21. Developing a CRISPR/Cas9 System for Genome Editing in the Basidiomycetous Yeast Rhodosporidium toruloides.
    Jiao X; Zhang Y; Liu X; Zhang Q; Zhang S; Zhao ZK
    Biotechnol J; 2019 Jul; 14(7):e1900036. PubMed ID: 31066204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compact CRISPR genetic screens enabled by improved guide RNA library cloning.
    Heo SJ; Enriquez LD; Federman S; Chang AY; Mace R; Shevade K; Nguyen P; Litterman AJ; Shafer S; Przybyla L; Chow ED
    Genome Biol; 2024 Jan; 25(1):25. PubMed ID: 38243310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.
    Ryø LB; Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():93-109. PubMed ID: 30912042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency.
    Hiranniramol K; Chen Y; Liu W; Wang X
    Bioinformatics; 2020 May; 36(9):2684-2689. PubMed ID: 31971562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient multiplex genome editing by CRISPR/Cas9 in common wheat.
    Li J; Zhang S; Zhang R; Gao J; Qi Y; Song G; Li W; Li Y; Li G
    Plant Biotechnol J; 2021 Mar; 19(3):427-429. PubMed ID: 33150679
    [No Abstract]   [Full Text] [Related]  

  • 26. CRISPR-Cas9-Edited Site Sequencing (CRES-Seq): An Efficient and High-Throughput Method for the Selection of CRISPR-Cas9-Edited Clones.
    Veeranagouda Y; Debono-Lagneaux D; Fournet H; Thill G; Didier M
    Curr Protoc Mol Biol; 2018 Jan; 121():31.14.1-31.14.11. PubMed ID: 29337372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR Guide RNA Library Screens in Human Induced Pluripotent Stem Cells.
    Zhou Y; Fu Q; Shi H; Zhou G
    Methods Mol Biol; 2022; 2549():233-257. PubMed ID: 35347694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-P 2.0: An Improved CRISPR-Cas9 Tool for Genome Editing in Plants.
    Liu H; Ding Y; Zhou Y; Jin W; Xie K; Chen LL
    Mol Plant; 2017 Mar; 10(3):530-532. PubMed ID: 28089950
    [No Abstract]   [Full Text] [Related]  

  • 29. CRISPR/Cas9 for Human Genome Engineering and Disease Research.
    Xiong X; Chen M; Lim WA; Zhao D; Qi LS
    Annu Rev Genomics Hum Genet; 2016 Aug; 17():131-54. PubMed ID: 27216776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-Throughput Approaches to Pinpoint Function within the Noncoding Genome.
    Montalbano A; Canver MC; Sanjana NE
    Mol Cell; 2017 Oct; 68(1):44-59. PubMed ID: 28985510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next-Generation Sequencing of Genome-Wide CRISPR Screens.
    Yau EH; Rana TM
    Methods Mol Biol; 2018; 1712():203-216. PubMed ID: 29224076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooled CRISPR Screens in Drosophila Cells.
    Viswanatha R; Brathwaite R; Hu Y; Li Z; Rodiger J; Merckaert P; Chung V; Mohr SE; Perrimon N
    Curr Protoc Mol Biol; 2019 Dec; 129(1):e111. PubMed ID: 31763777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells.
    Hendel A; Bak RO; Clark JT; Kennedy AB; Ryan DE; Roy S; Steinfeld I; Lunstad BD; Kaiser RJ; Wilkens AB; Bacchetta R; Tsalenko A; Dellinger D; Bruhn L; Porteus MH
    Nat Biotechnol; 2015 Sep; 33(9):985-989. PubMed ID: 26121415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pooled Lentiviral CRISPR-Cas9 Screens for Functional Genomics in Mammalian Cells.
    Aregger M; Chandrashekhar M; Tong AHY; Chan K; Moffat J
    Methods Mol Biol; 2019; 1869():169-188. PubMed ID: 30324523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. gRNA-transient expression system for simplified gRNA delivery in CRISPR/Cas9 genome editing.
    Easmin F; Hassan N; Sasano Y; Ekino K; Taguchi H; Harashima S
    J Biosci Bioeng; 2019 Sep; 128(3):373-378. PubMed ID: 31010727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing Rice Mutants Using CRISPR/Cas9-Based Genome Editing Technology.
    Xu K; Li Y
    Methods Mol Biol; 2022; 2400():11-19. PubMed ID: 34905186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5S rRNA Promoter for Guide RNA Expression Enabled Highly Efficient CRISPR/Cas9 Genome Editing in
    Zheng X; Zheng P; Zhang K; Cairns TC; Meyer V; Sun J; Ma Y
    ACS Synth Biol; 2019 Jul; 8(7):1568-1574. PubMed ID: 29687998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR/Cas9-mediated 2-sgRNA cleavage facilitates pseudorabies virus editing.
    Tang YD; Guo JC; Wang TY; Zhao K; Liu JT; Gao JC; Tian ZJ; An TQ; Cai XH
    FASEB J; 2018 Aug; 32(8):4293-4301. PubMed ID: 29509513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.